Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Rocket Pharmaceuticals, INC., €6,692. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Shah Gaurav: trading record in brief
All filings by Shah Gaurav on record concern Rocket Pharmaceuticals, Inc. The record holds 2 filings, for trades running from 13 August 2026 to 18 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 August 2026, reports a transaction of €6,692 in Rocket Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shah Gaurav
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,293 shares@ US$3.3814CommonSEC144:0001959173-26-006169
2,837 shares@ US$3.38110.0026% mcap0.4% of flowCommonSEC144:0001959173-26-005994
2 of 2 declarations
